Research is exploring the connection between nucleotide synthesis and cancer, with studies indicating that various oncogenes and signaling pathways can drive nucleotide biosynthesis to promote cancer development and resistance to treatment. Different types of cancer, including non-small cell lung cancer, pancreatic cancer, and T cell acute lymphoblastic leukemia, appear to be supported by altered nucleotide metabolism. The role of nucleotide synthesis in cancer is being investigated as a potential target for precision cancer therapy.